Literature DB >> 17369859

Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc.

T Sumi1, N Tsuneyoshi, N Nakatsuji, H Suemori.   

Abstract

Embryonic stem (ES) cells are self-renewing, pluripotent cell lines, characterized by their potential to differentiate into all cell types. The proto-oncogene product c-Myc has a crucial role in the self-renewal of mouse ES (mES) cells, but its role in human ES (hES) cells is unknown. To investigate c-Myc functions in hES cells, we expressed an inducible c-Myc fused to the hormone-binding domain of the estrogen receptor (c-MycER) protein that is activated by 4-hydroxy-tamoxifen. In contrast to its role in mES cells, activation of c-MycER in hES cells induced apoptosis and differentiation into extraembryonic endoderm and trophectoderm lineages concomitant with reduced expression of the pluripotent markers Oct4 and Nanog. Neither inhibition of caspase activity nor knockdown of p53 by RNA interference impaired the induction of differentiation markers induced by c-Myc activation. In addition, differentiation induced by c-Myc activation was associated with downregulation of alpha6 integrin expression, suggesting an important role for the integrin/extracellular matrix interaction in the regulation of ES cell behavior. None of these effects occurred with deletion of the c-Myc transactivation domain, indicating that c-Myc promotes both apoptosis and differentiation in a transcriptional activity-dependent manner. Together, our results provide new insights into the c-Myc functions regulating hES cell fate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369859     DOI: 10.1038/sj.onc.1210353

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  myc maintains embryonic stem cell pluripotency and self-renewal.

Authors:  Natalia V Varlakhanova; Rebecca F Cotterman; Wilhelmine N deVries; Judy Morgan; Leah Rae Donahue; Stephen Murray; Barbara B Knowles; Paul S Knoepfler
Journal:  Differentiation       Date:  2010-05-27       Impact factor: 3.880

Review 2.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 3.  Advances in reprogramming somatic cells to induced pluripotent stem cells.

Authors:  Minal Patel; Shuying Yang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 4.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

5.  Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.

Authors:  Vladimir Vinarsky; Jan Krivanek; Liina Rankel; Zuzana Nahacka; Tomas Barta; Josef Jaros; Ladislav Andera; Ales Hampl
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

6.  Disruption of Smad4 in mouse epidermis leads to depletion of follicle stem cells.

Authors:  Leilei Yang; Lijuan Wang; Xiao Yang
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

7.  Neuronal Differentiation of a Human Induced Pluripotent Stem Cell Line (FS-1) Derived from Newborn Foreskin Fibroblasts.

Authors:  Jihye Kwon; Nayeon Lee; Iksoo Jeon; Hey Jin Lee; Jeong Tae Do; Dong Ryul Lee; Seung-Hun Oh; Dong Ah Shin; Aeri Kim; Jihwan Song
Journal:  Int J Stem Cells       Date:  2012-11       Impact factor: 2.500

8.  The SMAD2/3 corepressor SNON maintains pluripotency through selective repression of mesendodermal genes in human ES cells.

Authors:  Norihiro Tsuneyoshi; Ee Kim Tan; Akila Sadasivam; Yogavalli Poobalan; Tomoyuki Sumi; Norio Nakatsuji; Hirofumi Suemori; N Ray Dunn
Journal:  Genes Dev       Date:  2012-11-15       Impact factor: 11.361

9.  Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.

Authors:  Si Luo; Zhen Pan; Shuang Liu; Shujing Yuan; Nianlong Yan
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

10.  Keeping an eye on retinoblastoma control of human embryonic stem cells.

Authors:  Jamie F Conklin; Julien Sage
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.